|Articles|October 25, 2011

Medical Economics Digital Edition - 10/25/2011

Road to Meaningful Use

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Medical Economics Digital Edition - 10/25/2011

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Trending on Medical Economics

Sen. Roger Marshall's obstetrics practice sued more than 700 patients over unpaid bills

The 10 least vaccinated states in 2026

Bipartisan Senate bill would send $10 billion to primary care and rework how Medicare values physician work

Hospital consolidation: Making primary care more integrated — and more expensive

What physicians should know about community health workers before Medicaid work requirements take effect